Author:
Kaizer Alexander M.,Moore Susan L.,Banaei-Kashani Farnoush,Bull Sheana,Rosenberg Michael A.
Abstract
AbstractBackgroundN-of-1 trials have been proposed as an approach to identify the optimal individual treatment for patients with a number of recurrent medical conditions, including chronic pain and mental health. When inserted into mHealth applications, this approach holds great promise to provide an automated, efficient method to individualize patient care; however, prior to implementation, an understanding of the properties of the recurrent condition needed to draw conclusions with sufficient power is needed.MethodsWe applied simulation studies and power calculations to determine statistical properties of the N-of-1 approach employed by an mHealth application for self-management of chronic recurrent medical conditions called the iMTracker.ResultsIn 1000 simulated patients with a single recurrent medical condition and 5 possible associated conditions, we found that ~90 days of data collection was sufficient to identify associated risk factors with odds ratio (OR > 5.0) at power ≥ 80%, with an absolute event rate of 50% being optimal. Power calculations based on Fisher’s Exact test showed that 90 days was also sufficient to detect a decrease of 20% in the rate of the primary outcome after an intervention, but that shorter data periods could be used to identify stronger effect sizes, down to 15 days with a 90% reduction in rate. Repeat analysis with Bayesian models did not significantly change power calculations, but did allow for a flexible approach that we leveraged to create a web-based tool to allow users to perform power calculations prior to using the iMTracker for self-management.ConclusionsWe found that the N-of-1 approach employed in the iMTracker app for self-management of recurrent medical conditions is statistically feasible, given the right conditions. More work is needed to examine the impact of autocorrelation, seasonality, and trends in data, on statistical validity and power calculations.
Publisher
Cold Spring Harbor Laboratory
Reference32 articles.
1. Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society;Practice guideline update summary;Neurology,2020
2. Leung A , Shirvalkar P , Chen R , Kuluva J , Vaninetti M , Bermudes R , Poree L , Wassermann E , Kopell B and Levy R . Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS Expert Consensus Panel Review and Recommendation. Neuromodulation: journal of the International Neuromodulation Society. 2020.
3. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components
4. Ng JY and Mohiuddin U . Quality of complementary and alternative medicine recommendations in low back pain guidelines: a systematic review. European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2020.
5. Issues of comorbidity in clinical guidelines and systematic reviews from a rehabilitation perspective;European journal of physical and rehabilitation medicine,2019